Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.71% | 30.26 | 14.1% | $178.05m | |
| AMRN | Amarin Corp. Plc | -0.75% | 19.91 | 1.7% | $164.99m | |
| AXSM | Axsome Therapeutics, Inc. | -2.31% | 90.34 | 1.9% | $138.85m | |
| SAVA | Cassava Sciences, Inc. | -4.40% | 8.25 | 0.0% | $90.26m | |
| ARQL | ArQule, Inc. | 0.15% | 20.00 | 0.6% | $80.30m | |
| BHC | Bausch Health Cos., Inc. | 1.71% | 30.26 | 0.0% | $72.67m | |
| SAGE | SAGE Therapeutics, Inc. | 3.12% | 76.40 | 8.6% | $71.43m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.36% | 151.05 | 2.3% | $68.74m | |
| GWPH | GW Pharmaceuticals Plc | -0.13% | 118.97 | 6.2% | $67.44m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.76% | 106.11 | 16.9% | $60.73m | |
| PRGO | Perrigo Co. Plc | -0.82% | 59.02 | 6.8% | $58.59m | |
| HZNP | Horizon Therapeutics Plc | 0.29% | 38.40 | 6.6% | $58.11m | |
| ICLR | ICON plc | 0.38% | 175.78 | 4.2% | $42.92m | |
| ENDP | Endo International Plc | -2.27% | 6.04 | 8.8% | $42.08m | |
| CTLT | Catalent, Inc. | -1.03% | 60.84 | 2.4% | $38.13m |
Company Profile
MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.